Filter

Refine by Subjects

Refine by Access

Refine by Type

Refine by Date

—
  • Print
  • Save

Search Results

You are looking at 141 - 150 of 317 items for

  • Author or Editor: Rita K. Jew x
  • Refine by Access: All content x
Clear All Modify Search
Restricted access

Rifampin Suspension 25 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Rifampin Syrup 10 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Rifaximin Suspension 20 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Rosuvastatin Suspension 4 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Sodium Benzoate Syrup 250 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Sodium Phenylbutyrate Suspension 200 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Atenolol Syrup 2 mg/mL—Formulation 1*

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Spironolactone 5 mg/mL and Hydrochlorothiazide 5 mg/mL Suspension—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Spironolactone 5 mg/mL and Hydrochlorothiazide 5 mg/mL Suspension—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022
Restricted access

Sulfadiazine Suspension 100 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Chapter

Cover Extemporaneous Formulations

In  Extemporaneous Formulations

Published (Print):
Jan 2022